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ABSTRACT To cause infection, Staphylococcus aureus must withstand damage
caused by host immune defenses. However, the mechanisms by which staphylococ-
cal DNA is damaged and repaired during infection are poorly understood. Using a
panel of transposon mutants, we identified the rexBA operon as being important for
the survival of Staphylococcus aureus in whole human blood. Mutants lacking rexB
were also attenuated for virulence in murine models of both systemic and skin in-
fections. We then demonstrated that RexAB is a member of the AddAB family of he-
licase/nuclease complexes responsible for initiating the repair of DNA double-strand
breaks. Using a fluorescent reporter system, we were able to show that neutrophils
cause staphylococcal DNA double-strand breaks through reactive oxygen species
(ROS) generated by the respiratory burst, which are repaired by RexAB, leading to
the induction of the mutagenic SOS response. We found that RexAB homologues in
Enterococcus faecalis and Streptococcus gordonii also promoted the survival of these
pathogens in human blood, suggesting that DNA double-strand break repair is re-
quired for Gram-positive bacteria to survive in host tissues. Together, these data
demonstrate that DNA is a target of host immune cells, leading to double-strand
breaks, and that the repair of this damage by an AddAB-family enzyme enables the
survival of Gram-positive pathogens during infection.
IMPORTANCE To cause infection, bacteria must survive attack by the host immune
system. For many bacteria, including the major human pathogen Staphylococcus au-
reus, the greatest threat is posed by neutrophils. These immune cells ingest the in-
vading organisms and try to kill them with a cocktail of chemicals that includes re-
active oxygen species (ROS). The ability of S. aureus to survive this attack is crucial
for the progression of infection. However, it was not clear how the ROS damaged S.
aureus and how the bacterium repaired this damage. In this work, we show that
ROS cause breaks in the staphylococcal DNA, which must be repaired by a two-
protein complex known as RexAB; otherwise, the bacterium is killed, and it cannot
sustain infection. This provides information on the type of damage that neutrophils
cause S. aureus and the mechanism by which this damage is repaired, enabling in-
fection.
KEYWORDS respiratory burst, oxidative burst, DNA damage, Enterococcus, SOS
system, Staphylococcus, Streptococcus, neutrophils
The ability of Staphylococcus aureus to maintain the integrity of its DNA in the faceof reactive oxygen and nitrogen species produced by host immune defenses is
crucial for the establishment of infection. However, despite the importance of DNA
repair for staphylococcal survival in the host, little is known about the processes
responsible, with most functions based on inferences from work done with the model
organisms Bacillus subtilis or Escherichia coli (1, 2).
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This is important because S. aureus is responsible for a raft of serious invasive
infections, including bacteremia, infective endocarditis, and osteomyelitis (3). Despite a
potent immune response, many infections become chronic or recurrent (4), implying
either that S. aureus does not experience DNA damage during infection or that it has
efficient mechanisms for damage repair.
The entry of S. aureus into normally sterile tissues triggers the infiltration of
neutrophils to control infection (5–7). Neutrophils phagocytose S. aureus and expose
the bacterium to a cocktail of antimicrobial peptides and proteases (8–10), reactive
nitrogen species, and reactive oxygen species (ROS) that are generated by the respi-
ratory burst (also known as the oxidative burst) (11–16). While the contribution of each
ROS to bactericidal activity is the subject of investigation, there is compelling evidence
that the respiratory burst is crucial for the control of S. aureus infection (13, 16, 17). For
example, individuals with chronic granulomatous disease (CGD) are particularly prone
to staphylococcal infections because their neutrophils are defective for the respiratory
burst (6, 18). In keeping with this, S. aureus survives better in mice defective for the
respiratory burst than in wild-type animals, while the treatment of human neutrophils
with an inhibitor of the respiratory burst increased staphylococcal survival relative to
untreated immune cells (7–9, 13, 19). However, even when the respiratory burst is
functional, there is evidence that some S. aureus cells can survive in neutrophils, which
contributes to the progression of infection (8, 9).
Despite the importance of the respiratory burst in combating staphylococcal infec-
tion, relatively little is known about how it kills the pathogen. Studies with single
oxidants such as H2O2 indicate that the molecular targets of the respiratory burst are
broad and include proteins, lipids, and DNA (20). To survive this damage, S. aureus
employs several stress response regulators and repair systems. For example, previous
work has shown that DNA damage caused by S. aureus exposure to H2O2 leads to the
initiation of the DNA repair SOS response (21), which facilitates the excision of damaged
bases or the repair of double-strand breaks (DSBs) by homologous recombination (22).
However, H2O2 is a suboptimal model for the ROS produced by the respiratory burst
because it is typically used at concentrations that exceed those generated by the
respiratory burst (23). Therefore, it is unclear whether staphylococcal DNA is damaged
by neutrophil-generated ROS, what the nature of this damage is, how it is repaired by
S. aureus, and the impact of this damage on infection.
To address this gap in our knowledge, we examined mutants defective for DNA
repair and found that a member of the AddAB helicase/nuclease family of enzymes was
required for staphylococcal survival in blood and murine models of systemic and skin
infections. We also demonstrated that this complex is required for the repair of DNA
double-strand breaks caused by ROS produced by the respiratory burst of neutrophils,
which leads to the induction of the mutagenic SOS response. Similar complexes were
required for the survival of the infective endocarditis pathogens Streptococcus gordonii
and Enterococcus faecalis in human blood, demonstrating that DNA damage repair is an
important mechanism by which Gram-positive pathogens withstand host defenses.
RESULTS
RexAB is required for staphylococcal survival in host tissues. To determine
whether DNA damage occurs under infection conditions, we assembled a panel of S.
aureus mutants from the ordered Nebraska transposon library produced by the Net-
work on Antimicrobial Resistance in S. aureus (NARSA) (24). Each mutant was defective
for a different protein associated with DNA repair, which would enable the nature of
any damage to be identified. We then assessed the contribution of each repair protein
to bacterial survival in the host by measuring CFU counts of mutants in an ex vivo whole
human blood model of infection. Previous characterizations of this model system by
our group and others have shown that S. aureus is rapidly phagocytosed by neutrophils
and exposed to ROS and other killing mechanisms (25–27).
Wild-type (WT) S. aureus JE2 survived relatively well in human blood, with 60% of
the inoculum being viable after 2 h (see Fig. S1 in the supplemental material). In
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contrast, the survival of mutants defective for rexA or rexB was 5% of the inoculum
(Fig. S1). Since the transposon insertion in rexB contains a terminator sequence that
prevents the transcription of rexA, the second gene in the operon, rexB mutants are
defective for both rexB and rexA and are effectively rexBA mutants (24). Therefore, we
confirmed the importance of RexAB for the survival of two distinct strains (JE2 and
SH1000) in blood by complementation of the rexB mutants with a plasmid containing
the rexBA operon (prexBA), which restored bacterial survival to wild-type levels (Fig. 1A
and B). In contrast, the survival of rexB mutants transformed with the vector alone
(pEmpty) was not changed from that of the mutant (Fig. 1A and B).
FIG 1 Survival of the rexB mutant is significantly reduced in human blood and in vivo murine infection models. (A and B)
Survival of the S. aureus wild type (WT), the rexB mutant, the empty vector (pEmpty), and the complemented mutant
(prexBA) in the SH1000 (A) and JE2 (B) backgrounds after 6 h of incubation in whole human blood. Empty vectors and
complemented mutants were supplemented with 100 ng/ml AHT (anhydrotetracycline) to induce rexBA expression (n  3).
(C and D) Numbers of CFU recovered from the peritoneal cavities of mice at 6 h postinfection (each circle represents a
single mouse; n  4 to 5). (E) CFU per milliliter recovered from mouse skin biopsy specimens at 5 days postinfection (each
circle represents a single mouse; n  12). (F) Sizes of skin lesions observed on mice at up to 5 days postinfection (n  12).
Data in panels A and B were analyzed by one-way ANOVA with Tukey’s post hoc test relative to the WT (*, P  0.05). Data
in panels C to F were analyzed by a Mann-Whitney test (*, P  0.05). NS, not significant.
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Having shown that RexAB contributed to staphylococcal tolerance of neutrophil-
mediated killing in human blood, we then tested its role in staphylococcal survival in
vivo using a murine model of systemic infection. Mice were infected via the peritoneal
cavity, which results in the recruitment of neutrophils within 2 h, with wild-type or rexB
mutant strains of S. aureus SH1000 or JE2 (28). After 6 h, the mice were sacrificed, and
the peritoneal cavity was washed with phosphate-buffered saline (PBS) to recover
bacteria, which were quantified by CFU counts. This revealed that rexB mutants in both
genetic backgrounds were significantly attenuated for survival in vivo, with 5-fold-
lower CFU counts than those of the respective wild-type bacteria (P  0.05), confirming
that RexAB contributes to staphylococcal resistance to host immune defenses and the
progression of systemic infection (Fig. 1C and D).
Because S. aureus causes many different types of infection, and the associated
immune responses might vary, we next assessed the survival of wild-type strain JE2 and
the rexB mutant in a murine skin infection model. Mice were infected via subcutaneous
injection, and infection was allowed to progress for 5 days before CFU counts at
inoculation sites were determined. This revealed that wild-type bacteria were present
at 2- to 3-fold-higher levels than the rexB mutant (P  0.05) (Fig. 1E). We also measured
the sizes of the skin lesions generated by injected S. aureus. Wild-type JE2 caused a
lesion that progressively increased in size over time (Fig. 1F). In contrast, the lesion
caused by the rexB mutant did not increase after day 2 and was significantly smaller
than that caused by the wild type for days 2, 3, 4, and 5 (Fig. 1F; Fig. S2). This indicated
that RexAB was also required for skin infection progression.
To understand whether the reduced CFU counts of the rexB mutants relative to the
wild type in animal models were due to differences in growth rates or reduced
virulence factor production, we measured bacterial growth, hemolysin production,
staphyloxanthin levels, and catalase levels across JE2 and SH1000 wild-type and mutant
strains. For both JE2 and SH1000, the rexB mutant replicated at a slightly lower rate
than the wild type, but there were no significant differences in the production of
hemolysin, staphyloxanthin, or catalase (Fig. S3). Taken together, these findings dem-
onstrate that RexAB significantly promotes staphylococcal survival in host tissues and
is required for infection progression.
RexAB is a member of the AddAB family of ATP-dependent helicase/nucleases.
The rexA and rexB genes form a two-gene operon (rexBA) on the staphylococcal
chromosome and are proposed to encode an AddAB helicase/nuclease enzyme on the
basis of sequence homology (29–32). However, this had not been demonstrated
experimentally.
Our initial in silico structural analysis of the predicted rexBA gene products sup-
ported predictions that this operon encodes an AddAB-type ATP-dependent helicase/
nuclease that contributes to the processing and repair of DNA DSBs (Fig. S4). AddAB
enzymes process DSBs to generate a 3= single-stranded DNA (ssDNA) overhang that is
necessary for RecA-mediated homologous recombination (33). In support of the struc-
tural predictions, phenotypic testing of rexBA mutants showed that they were 8-fold
more susceptible than wild-type strains to the DNA-damaging antibiotics ciprofloxacin
and mitomycin C, both of which cause DNA DSBs (34, 35) (Fig. S5).
To confirm the ATP-dependent helicase/nuclease activity of the S. aureus RexAB
complex, recombinant RexAB protein was generated, and the helicase and nuclease
activities were measured over 1 h. Nuclease activity assays were performed under
conditions of high free Mg2, which has been previously shown to activate nu-
clease activity in AddAB enzymes (36). We found that DNA was degraded over time
by the recombinant complex in the presence of ATP, whereas this degradation was
minimal in its absence, demonstrating that RexAB has ATP-dependent nuclease
activity (Fig. 2A).
We measured helicase activity under conditions of low free Mg2 levels and
observed a loss of double-stranded DNA (dsDNA) concomitant with increased
ssDNA formation over time (Fig. 2B and C). These experiments were repeated in the
absence of single-stranded DNA binding protein (SSB), which is required to prevent
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the reannealing of DNA. In the absence of SSB, no DNA unwinding or ssDNA
formation was observed, demonstrating that RexAB has ATP-dependent helicase
activity (Fig. 2D and E).
Combined, these results confirm that RexAB is a functional member of the AddAB
family of DNA repair complexes. In turn, this demonstrates that DNA DSBs occur during
staphylococcal infection and must be repaired for bacterial survival.
RexAB enables staphylococcal tolerance of ROS produced by the respiratory
burst. Having confirmed that DNA DSBs occur in S. aureus during infection, we wanted
FIG 2 RexAB possesses ATP-dependent nuclease and helicase activities. (A) Nuclease activity of recombinant S. aureus
RexAB protein in the presence or absence of ATP (n  4). (B to E) Helicase activity of recombinant S. aureus RexAB protein
in the presence or absence of ATP, determined by measuring the unwinding of dsDNA and the formation of ssDNA. (B and
C) Single-stranded DNA binding protein (SSB) was added to prevent the reannealing of DNA (n  4). (D and E) Equivalent
assays were performed without SSB to confirm helicase activity (n  4). Data in panels A to C were analyzed by two-way
ANOVA with Sidak’s post hoc test comparing activities without versus those with ATP (*, P  0.05). Error bars represent
standard deviations of the means.
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to determine whether this was due to ROS produced by the respiratory burst of
neutrophils. Therefore, we incubated wild-type and rexB mutant strains in whole
human blood in the presence of diphenyleneiodonium chloride (DPI) to block the
NADPH oxidase-generated respiratory burst or dimethyl sulfoxide (DMSO) alone as a
solvent control.
As shown in Fig. 1A and B, the survival of rexB mutants in whole human blood was
significantly reduced relative to that of wild-type bacteria (Fig. 3A and B). However, the
presence of DPI promoted the survival of rexB mutants to wild-type levels, indicating
that the survival deficit observed for bacteria lacking RexAB was due to increased
FIG 3 RexAB protects S. aureus from ROS produced by the respiratory burst of neutrophils and when exposed to H2O2.
(A and B) Survival of the S. aureus WT, the rexB mutant, the empty vector (pEmpty), and the complemented mutant
(prexBA) in the SH1000 (A) and JE2 (B) backgrounds in whole human blood after 6 h of incubation in the presence of
the respiratory burst inhibitor DPI or an identical volume of the DMSO solvent alone. Empty vectors and complemented
mutants were supplemented with 100 ng/ml AHT to control rexBA expression (n  3). (C and D) Survival of S. aureus
WT and rexB mutant strains incubated with purified human neutrophils for 3 h (n  4). (E and F) Survival of the S. aureus
WT, the rexB mutant, the empty vector (pEmpty), and the complemented mutant (prexBA) after 1 h of incubation with
10 mM H2O2. Empty vectors and complemented mutants were supplemented with 100 ng/l AHT to induce rexBA
expression (n  3). Data in panels A and B were analyzed by one-way ANOVA with Tukey’s post hoc test relative to the
WT (*, P  0.05). Data in panels C and D were analyzed by Student’s t test relative to the WT (*, P  0.05). Error bars
represent standard deviations of the means. Data in panels E and F were analyzed by one-way ANOVA with Dunnett’s
post hoc test relative to the WT (*, P  0.05).
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sensitivity to ROS produced by the respiratory burst (Fig. 3A and B). To ensure that the
killing of rexB mutants in blood was due to neutrophils, S. aureus strains were incubated
with purified human neutrophils, and survival was measured via CFU counts. Similar to
whole blood, rexB mutants were more susceptible to neutrophil-mediated killing than
the wild type, but the presence of DPI restored the survival of the rexB mutants to
wild-type levels (Fig. 3C and D). These data strongly indicated that RexAB contributed
to staphylococcal survival of DNA damage caused by ROS produced by the respiratory
burst.
To confirm that rexB mutants were more susceptible to oxidative damage, we
measured the survival of S. aureus strains in H2O2, which is one of several different ROS
produced in the respiratory burst (6). As observed for whole human blood and purified
neutrophils, rexB mutants were more susceptible to H2O2 than the wild-type or
complemented strains (Fig. 3E and F).
Together, these data demonstrate that neutrophils cause DNA DSBs in S. aureus via
ROS produced by the respiratory burst. This damage must be repaired by RexAB to
enable staphylococcal survival in the host.
RexAB is required for induction of the SOS response during exposure to ROS
produced by the respiratory burst. The processing of DNA DSBs by AddAB proteins
leads to the generation of a 3= overhang. This results in the formation of a RecA
filament, which triggers the SOS response, a multicomponent DNA repair mechanism
that mediates the repair of the DNA DSB (1, 22). However, the induction of the SOS
response also leads to a transient increase in the mutation rate, which promotes the
emergence of mutants with resistance to antibiotics or host-adapted phenotypes such
as small-colony variants (2, 37).
Therefore, we tested whether ROS produced by the respiratory burst triggers the
SOS response and whether this was dependent upon RexAB. To do this, we used a
PrecA-gfp reporter construct and validated it by showing dose-dependent activity with
mitomycin C, a well-established trigger of the SOS response (38) (Fig. S6). We then
incubated tetramethyl rhodamine isothiocyanate (TRITC)-labeled S. aureus JE2 wild type
and rexB mutant strains containing the reporter with neutrophils for 30 min and used
flow cytometry to measure phagocytosis and reporter activity (green fluorescent
protein [GFP] fluorescence) (Fig. S7) (39). As reported previously, 95% of S. aureus cells
were associated with neutrophils within 30 min (Fig. 4A) (26). Also, by 30 min, there was
an increase in the GFP signal from wild-type S. aureus relative to the start of the assay
(Fig. 4B). In contrast, there was no increase in the GFP signal from the rexB mutant
(Fig. 4B), indicating that neutrophils trigger the SOS response in S. aureus via DNA
processing by RexAB.
To further explore the requirement for RexAB for the induction of the SOS response
during exposure to oxidative stress, wild-type and rexB mutant bacteria were incubated
with various subinhibitory doses of paraquat, which results in the generation of
endogenous superoxide, which dismutates to H2O2. For wild-type bacteria, there was a
clear dose-dependent increase in GFP-mediated fluorescence, indicative of SOS induc-
tion (Fig. 4C). For the rexB mutant, while there also appeared to be a dose-dependent
induction of the SOS response, it was at considerably lower levels than those seen for
the wild type (Fig. 4C). Therefore, the induction of SOS in response to oxidative stress
is almost entirely dependent upon RexAB-mediated processing of DNA DSBs.
RexAB is required for survival of streptococci and enterococci in human blood.
Since homologues of RexAB are present in most Gram-positive bacteria (31–33), we
next tested whether this repair complex contributes to the survival of other bacteria
exposed to neutrophils. Like S. aureus, Enterococcus faecalis and Streptococcus gordonii
are frequent causes of infective endocarditis, which brings these species into close
contact with neutrophils (40, 41). Therefore, rexBA was deleted in representative strains
of each species, and their sensitivity to the microbicidal activity of neutrophils was
determined using the ex vivo whole human blood model. To confirm that RexAB
mediates the repair of DNA DSBs in both bacteria, we also assessed their susceptibility
to the antibiotics ciprofloxacin, which causes DNA DSBs (42), and gentamicin, which
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targets protein synthesis and thus acted as a negative control (43). For both S. gordonii
and E. faecalis, the ΔrexBA mutants were significantly more susceptible to ciprofloxacin
than the wild type, confirming that RexAB in these bacteria contributes to DNA DSB
repair (Table S1). In contrast, both the wild type and the ΔrexBA mutants were equally
susceptible to the antibiotic gentamicin (Table S1).
Wild-type E. faecalis survived at high levels in human blood, with 100% of the
inoculum remaining viable during the full 6-h duration of the assay, but the loss of
rexBA reduced enterococcal survival by 50% (Fig. 5A). This indicated that E. faecalis
suffers DNA damage that results in DSBs while in blood, but it can be tolerated via DNA
repair (Fig. 5A). However, in contrast to S. aureus, DNA damage in E. faecalis was not due
to ROS produced by the respiratory burst since the survival of both wild-type and rexB
mutant bacteria in blood was unaffected by the presence of DPI (Fig. 5A).
S. gordonii was much more susceptible to host defenses in blood than E. faecalis,
with 5% of wild-type bacteria remaining viable after 6 h (Fig. 5A). However, the
survival of the rexBA mutant was still reduced relative to the wild type, with 1% of
streptococci surviving after 6 h, indicating that DNA DSB repair also contributes to the
survival of S. gordonii in blood (Fig. 5A). As for E. faecalis, the presence of DPI did not
increase the survival of S. gordonii in blood, indicating that DNA damage was not due
to ROS produced by the respiratory burst in either bacterium. In support of these
findings, the rexBA mutants of both S. gordonii and E. faecalis were no more susceptible
to H2O2 than wild-type bacteria (Fig. 5B).
FIG 4 RexAB is required for induction of the SOS response during exposure to ROS produced by the respiratory burst of
neutrophils and when exposed to the ROS generator paraquat. (A and B) Phagocytosis (both ingested and surface-bound
bacteria [39]) of JE2 wild-type and rexB mutant recA-gfp reporter strains by neutrophils (A) and the resulting induction of
the SOS response measured by GFP expression (RFU) after 30 min of exposure (n  4) (B). (C) Induction of the SOS response
of JE2 wild-type and rexB mutant strains as measured by GFP expression upon exposure to sublethal concentrations of
paraquat. GFP fluorescence was normalized by the OD600 to determine the induction of SOS relative to the cell density
(n  4). OD600 measurements alone are shown in Fig. S5 in the supplemental material. Data in panels A and B were
analyzed by a Mann-Whitney test (*, P  0.05). Where shown, error bars represent standard deviations of the means. Error
bars were omitted from panels C and D for clarity.
Ha et al. ®
November/December 2020 Volume 11 Issue 6 e02288-20 mbio.asm.org 8
 on N
ovem








Therefore, as for S. aureus, neutrophils damage DNA of both S. gordonii and E.
faecalis, the repair of which by RexAB promotes bacterial survival. However, in contrast
to S. aureus, ROS generated by the neutrophil respiratory burst do not appear to
contribute to DNA damage in these bacteria.
DISCUSSION
Neutrophils are an essential host defense against S. aureus and many other bacterial
pathogens. However, our understanding of the mechanisms by which these immune
cells kill staphylococci is limited. The data presented here demonstrate that neutrophils
cause DNA damage in S. aureus via ROS produced by the respiratory burst, the repair
of which requires the RexAB complex and leads to the induction of the SOS response.
We also confirmed that RexAB is a member of the AddAB helicase/nuclease family of
enzymes involved in the processing of DNA DSBs for repair via homologous recombi-
nation. Thus, ROS generated by neutrophils cause DNA DSBs in S. aureus, which are
lethal if not repaired. This provides new information on both the target of the ROS
generated by the respiratory burst and the mechanisms by which S. aureus repairs and
survives this damage.
The importance of RexAB for staphylococcal survival during infection was demon-
strated in murine models of both systemic and skin infections as well as an ex vivo
whole human blood model of bacteremia. Since S. aureus is a frequent cause of both
superficial and systemic infections (3), these findings confirm the importance of DNA
repair for staphylococcal survival in relevant but distinct host tissues.
Previous work demonstrated the requirement of DNA DSB repair for the survival
of Gram-negative pathogens in vivo. For example, AddAB was shown to be required
FIG 5 RexAB protects Enterococcus faecalis and Streptococcus gordonii from host defenses in blood. (A)
Survival of E. faecalis and S. gordonii wild-type and ΔrexBA mutant strains in whole human blood after 6
h in the presence of the respiratory burst inhibitor DPI or an identical volume of the DMSO solvent alone
(n  3). (B) Survival of E. faecalis and S. gordonii wild-type and ΔrexBA mutant strains exposed to H2O2 for
1 h (n  3). Data in panels A and B were analyzed by Student’s t test comparing the ΔrexBA mutant versus
the WT (*, P  0.05). Error bars represent standard deviations of the means.
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for the infection of chickens and mice by Campylobacter jejuni and Helicobacter
pylori, respectively (44, 45). Furthermore, the virulence of Salmonella enterica in a
murine model of bacteremia was dependent upon the RecBCD DNA DSB repair
complex (46). However, the importance of such systems for Gram-positive bacteria
was unclear.
DNA damage occurred within 30 min of phagocytosis of S. aureus by neutrophils,
which corresponds to the time at which ROS are maximally generated in these immune
cells (47, 48). The finding that the respiratory burst leads to DNA DSBs in S. aureus is in
keeping with previous reports that ROS damage the DNA of Gram-negative pathogens
such as Escherichia coli, Salmonella enterica, and Coxiella burnetii, with the survival of
bacteria phagocytosed by macrophages being dependent upon RecBCD (46, 49, 50).
Therefore, DNA is a common target of ROS produced by phagocytic immune cells for
several different human pathogens.
The findings from this work build on previous studies of oxidative DNA damage and
repair and enable us to understand the sequence of events that occur during the
exposure of S. aureus to ROS of the respiratory burst. Of the ROS produced by
neutrophils, only H2O2 can cross the membrane due to its lack of charge (14, 15, 23).
In the cytoplasm, H2O2 reacts with iron in a process known as the Fenton reaction,
which leads to the generation of highly reactive hydroxyl radicals (14, 15, 20, 23). These
can damage DNA as well as the pool of nucleotides, leading to various types of lesions
(14, 15, 20, 23). Based on our findings, physiological concentrations of ROS produced by
neutrophils lead to DNA DSBs in S. aureus despite the numerous antioxidant defenses
of this pathogen (21, 25, 27). While some bacteria can engage in nonhomologous end
joining, most DSBs are repaired via homologous recombination (31, 33, 36). RexAB
processes the broken ends to produce single-stranded DNA to which RecA binds (1, 31,
33, 36). The resulting RecA nucleoprotein filament triggers the SOS response by
initiating the autocleavage of the LexA transcriptional repressor (1, 22, 51). As shown
here, DNA damage processed by RexAB results in the expression of recA, leading to
homologous recombination and survival of the bacterium. The SOS response also leads
to the expression of the low-fidelity DNA polymerase UmuC, which leads to a transient
increase in the mutation rate (21, 22). Previous work from our group has shown that
mutagenesis due to SOS induction as a consequence of oxidative stress leads to the
acquisition of mutations conferring antibiotic resistance and the small-colony pheno-
type associated with chronic infection and resistance to neutrophil-mediated killing (26,
37). Therefore, the processing of DNA DSBs by RexAB not only promotes the survival of
bacteria exposed to ROS produced by the respiratory burst but also may promote the
emergence of mutants that are more resistant to neutrophil-mediated killing by
triggering the SOS response. However, this remains to be tested.
In addition to S. aureus, the RexAB system was also demonstrated to be important
for the survival of the infective endocarditis pathogens E. faecalis and S. gordonii.
However, while neutrophils in blood caused DNA DSBs in these pathogens, this did not
appear to be due to ROS because the inhibition of NADPH oxidase with DPI had no
effect on the survival of the wild type or the rexBA mutants. Neutrophils employ several
different antibacterial elements to kill invading pathogens, including reactive oxygen
and nitrogen species, proteases, and antimicrobial peptides. Several studies have
indicated that bacteria vary in their susceptibility to each of these microbicides. In
agreement with our findings, Standish and Weiser showed that S. aureus but not
Streptococcus pneumoniae was killed by ROS (52). However, while S. aureus can grow in
the presence of nitric oxide, the replication of several other pathogens, including
Pseudomonas aeruginosa and Streptococcus pyogenes, is inhibited (53). Since reactive
nitrogen species can cause DNA damage, this may provide an explanation for the
finding that mutants of E. faecalis and S. gordonii lacking RexAB are more susceptible
to killing by neutrophils in which the respiratory burst is blocked.
While the consequences of RexAB-mediated processing of DNA DSBs are relatively
predictable for S. aureus, they are less so for E. faecalis and S. gordonii. This is particularly
the case for Streptococcus since this genus lacks the LexA repressor that is central to the
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control of the SOS response (54–56). However, S. gordonii encodes RecA, which
promotes survival during exposure to UV light, and there is evidence that the role of
LexA is fulfilled by HdiR in at least some streptococci and Lactococcus lactis (56–59). For
example, Streptococcus uberis has been found to encode a UmuC error-prone DNA
polymerase that appears to be regulated by HdiR and induced in response to UV-
mediated DNA damage, so it is possible that RexAB-mediated processing of DNA DSBs
leads to the induction of an SOS-like response in S. gordonii, including homologous
recombination and mutagenic DNA repair (56, 59).
In contrast to S. gordonii, E. faecalis encodes both RecA and LexA and appears to
have a DNA damage-inducible UmuC polymerase, suggesting a SOS response similar to
that described above for S. aureus (60–63). However, as for S. aureus, it remains to be
seen whether neutrophil-mediated DNA damage leads to an increase in the mutation
rate in either S. gordonii or E. faecalis.
In addition to providing protection from oxidative damage caused by neutrophils,
we have previously shown that RexAB provides S. aureus with tolerance to the
combination antibiotic co-trimoxazole (38). That work showed that DNA damage was
partly due to endogenous oxidative stress that occurred during exposure to the
combination antibiotic, in addition to direct damage to DNA caused by thymidine
limitation (38). The data presented here show that the loss of RexAB also sensitizes S.
aureus to ciprofloxacin, even though the JE2 strain is resistant. In addition, there is
growing evidence that multiple classes of antibiotics cause endogenous ROS produc-
tion in S. aureus, suggesting that RexAB may provide an important defense against
damage caused by both host defenses and multiple classes of antibiotics, the two key
threats to staphylococcal survival in the host. Further studies are needed to test this,
but the identification of RexAB as being important for staphylococcal survival during
exposure to both neutrophils and at least two antibiotics makes this complex a
potential target for novel therapeutics, particularly as the lack of RexAB homologues in
eukaryotes reduces the likelihood of host toxicity (64).
Inhibitors of AddAB and RecBCD have been previously reported in the literature, but
problems include limited in vivo stability, poor oral bioavailability, and a suboptimal
mechanism of action (65–68). However, Amundsen et al. identified several small-
molecule inhibitors of Helicobacter pylori AddAB and E. coli RecBCD, in particular ML328
(69), indicating that the development of stable, potent inhibitors is possible. More
recently, a derivative of ML328 (IMP-1700) was found to be capable of potentiating
antibiotic activity such that a resistant S. aureus strain was sensitized to ciprofloxacin
(70). However, the ability of IMP-1700 to inhibit AddAB/RecBCD activity under in vivo
conditions remains to be determined. Further work in this area may lead to broad-
spectrum therapeutics that promote bacterial susceptibility to both host defenses and
antibiotics as well as inhibiting the induction of the mutagenic SOS response associated
with the acquisition of drug resistance and host adaptation (37).
In summary, staphylococcal, streptococcal, and enterococcal DNA is damaged by
the host immune system, leading to DNA DSBs that are lethal if not repaired by RexAB.
These findings suggest that the RexAB complex is a potentially viable target for novel
therapeutics, capable of sensitizing Gram-positive pathogens to neutrophil-mediated
killing and blocking the SOS response associated with the emergence of drug resis-
tance.
MATERIALS AND METHODS
Bacterial strains and culture conditions. The bacterial strains used in this study are listed in Table 1.
S. aureus was cultured in tryptic soy broth (TSB) to stationary phase (18 h) at 37°C with shaking (180 rpm).
S. gordonii and E. faecalis were grown in Todd-Hewitt broth (THB) supplemented with 1% (wt/vol) yeast
extract (THB-Y) at 37°C, statically in 5% CO2. E. coli was grown in lysogeny broth (LB) or Terrific broth (TB)
(1.2% [wt/vol] tryptone, 2.4% [wt/vol] yeast extract, 0.5% glycerol, 0.17 M KH2PO4, 0.72 M K2HPO4) for
protein expression at 37°C with shaking (180 rpm). Media were supplemented with antibiotics as
required. When appropriate, bacteria were grown on Columbia blood agar (CBA) made with 5%
defibrinated sheep blood.
PrecA-gfp fluorescent reporter assay. As detailed previously (38), promoter-reporter gene con-
structs in the JE2 background were used to directly assess the expression of recA. Antibiotic 2-fold
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dilutions were made in flat-bottomed black-walled 96-well plates containing TSB and kanamycin (90 g
ml1) and inoculated with a 1/10 dilution of a stationary-phase culture of the reporter strains. Plates were
placed into an Infinite M200-Pro microplate reader (Tecan), where cultures were grown for 17 h at 37°C
(700 rpm), and both the absorbance at 600 nm (optical density at 600 nm [OD600]) and GFP relative
fluorescence units (RFU) were measured every 30 min.
OD600 data and RFU data were normalized to values for the no-antibiotic controls. To account for
differences in cell density, RFU values were normalized by the OD600 data at each time point.
Neutrophil phagocytosis and measurement of DNA damage. Whole human blood (15 ml) was
collected from individual healthy donors in EDTA-treated tubes (BD Biosciences) and layered over 20 ml
of room-temperature Polymorph prep (Alere Limited) before centrifugation at 500  g for 45 to 60 min
(brake off, 30°C) until a clear separation of red blood cells (RBCs), peripheral blood mononuclear cells
(PBMCs), and polymorphonuclear leukocytes (PMNs) (or neutrophils) was seen. The PBMCs were dis-
carded, and the PMNs were transferred to a fresh centrifuge tube. Hanks’ balanced salt solution (HBSS)
was added to the PMNs to a total volume of 50 ml, and cells were pelleted at 500  g for 10 min (brake
off, 30°C). The cells were resuspended in 3 ml of HBSS, counted using a hemocytometer, and adjusted to
5  106 cells ml1 in HBSS containing 10% human serum, 0.1 mM calcium, and 0.1 mM magnesium. To
the neutrophil suspension, 5  106 cells ml1 of bacteria (stationary- or exponential-phase TRITC-stained
bacteria) were added. The bacterium-neutrophil suspension was then incubated at 37°C with tumbling.
At each time point (0.5, 1, 2, and 3 h), 100 to 150 l was taken and resuspended in 4% paraformaldehyde
(PFA) in PBS for a minimum of 1 h. Before analysis by flow cytometry, samples were washed and
resuspended in PBS. Samples were analyzed on a FACSAria or LSRFortessa flow cytometer (BD Biosci-
ences), and at least 100,000 events were captured, except for bacterium-only samples, where at least
50,000 events were captured. Green fluorescence (GFP positive bacteria) was detected at 530 (30) nm,
and TRITC labeling was detected at 586 nm (16) nm. Full gating strategies are detailed in Fig. S6 and
Fig. S7 in the supplemental material. Measurements of phagocytosis include both ingested bacteria and
those bound to the surface of the neutrophil, based on that of Surewaard et al. (39).
Determination of MICs. MICs were determined using a serial broth dilution protocol as described
previously (71). Bacteria were diluted to 1  105 CFU ml1 and incubated in flat-bottomed 96-well plates
with a range of antibiotic concentrations for 17 h at 37°C under static conditions (aerobic, anaerobic, or
5% CO2). The MIC was defined as the lowest concentration at which no growth was observed.
Whole-blood and hydrogen peroxide survival assays. Bacteria were washed twice with PBS and
adjusted to 106 CFU ml1 in HBSS, and 104 CFU (10 l) were used to inoculate 90 l of freshly donated
human blood (collected in EDTA-treated tubes; BD Biosciences) or freshly diluted H2O2 (10 mM in PBS)
in 96-well plates. Ethical approval for drawing and using human blood was obtained from the Regional
Ethics Committee and the Imperial NHS Trust Tissue Bank (REC Wales approval no. 12/WA/0196 and





SH1000 rsbU derivative of laboratory strain 8325-4 80
SH1000 rexB::Tn SH1000 with a bursa aurealis transposon insertion in rexB; Eryr 38
SH1000 rexB::Tn pitet empty SH1000 with a bursa aurealis transposon insertion in rexB with the integrated pitet
empty plasmid; Eryr
38
SH1000 rexB::Tn pitet rexAB SH1000 with a bursa aurealis transposon insertion in rexB with integrated pitet with
AHT-inducible rexB; Eryr
38
JE2 Derivative of CA-MRSA USA300 LAC, cured of plasmids 24
JE2 rexB::Tn JE2 with a bursa aurealis transposon insertion in rexB; Eryr 24
JE2 rexB::Tn pitet empty JE2 with a bursa aurealis transposon insertion in rexB with the integrated pitet empty
plasmid; Eryr
38
JE2 rexB::Tn pitet rexAB JE2 with a bursa aurealis transposon insertion in rexB with integrated pitet with
AHT-inducible rexB; Eryr
38
JE2 pCN34 PrecA-gfp JE2 containing pCN34 with gfp under the control of the recA promoter; Kanr 38
JE2 rexB::Tn pCN34 PrecA-gfp JE2 rexB::Tn containing pCN34 with gfp under the control of the recA promoter; Kanr 38
Streptococcus gordonii
DL1 (Challis) Wild type 81
DL1 ΔrexBA DL1 with the rexA and rexB genes deleted This study
Enterococcus faecalis
CK111(pCF10-101) Conjugative donor strain with pCF10-101 76
OG1X Gelatinase deficient 82
OG1X ΔrexBA OG1X with the rexA and rexB genes deleted This study
Escherichia coli
EC1000 Cloning host that provides RepA in trans 83
SoluBL21(DE3) Derivative of BL21(DE3) for the expression of challenging proteins Genlantis
aCA-MRSA, community-acquired methicillin-resistant S. aureus.
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ICHTB HTA license no. 12275). In some assays, blood was pretreated for 10 min with diphenyleneiodo-
nium (DPI) (50 M) or an equivalent volume of DMSO as a solvent control. After 6 h of incubation,
bacterial survival was determined by CFU counts in blood-bacterium mixtures on CBA plates. For H2O2
assays, survival was measured after 1 h at 37°C (static) in the dark. Survival for both assays was calculated
as a percentage of the number of bacteria in the starting inoculum.
Neutrophil survival assay. Neutrophils were adjusted to 5  106 cells ml1 in HBSS containing 10%
human serum, 0.1 mM calcium, and 0.1 mM magnesium. Stationary-phase bacterial cultures were washed
in PBS, and 1  106 CFU were added to the neutrophil suspension (multiplicity of infection [MOI] of 1:5)
to a total volume of 1 ml. Neutrophils were treated for 10 min prior to the addition of bacteria with either DPI
(50 M) or an equivalent volume of DMSO (solvent control), as needed. The bacterium-neutrophil suspension
was subsequently incubated at 37°C with tumbling. At relevant time points (0.5, 1, 2, and 3 h), 50 l of the
suspension was transferred to a 96-well plate and serially diluted 10-fold in PBS up to a 103 dilution. All
dilutions (including neat) were then plated onto CBA and incubated for 24 h at 37°C before counting. Survival
was calculated as a percentage of the number of bacteria in the starting inoculum.
Murine systemic infection model. Animal work was conducted in accordance with the Animals
(Scientific Procedures) Act 1986 outlined by United Kingdom Home Office regulations. Work was
approved by the United Kingdom Home Office after ethical approval by the Imperial College Animal
Welfare and Ethical Review Body (AWERB). Six- to eight-week-old female C57BL/6 mice (Charles River)
were infected via the intraperitoneal route with the wild type or the rexB::Tn mutant in the JE2 and
SH1000 backgrounds. Stationary-phase bacterial cultures were washed twice with PBS and adjusted
to 107 CFU ml1. Subsequently, 400 l (4  106 CFU) of the washed bacterial suspensions was
injected into the peritoneal cavity of each mouse (5 mice for each strain; 20 in total). After 6 h, the
mice were humanely sacrificed by cervical dislocation, and death was confirmed by severing the
femoral artery. The peritoneal cavity was washed with PBS to release the bacteria, and CFU counts
were determined by plating onto tryptic soy agar (TSA). Sample size was determined prior to the
experiment using power analysis based on in vitro data (72). Tubes containing the bacterial
suspensions were blinded before the start of the experiment. Mice were randomly allocated to
group cages, and each group was randomly allocated to a treatment. According to Home Office
regulations, any animals that displayed two or more of the following symptoms were humanely
killed using a schedule 1 method and excluded from the study: shivering, hunched posture, reduced
movement, cyanosis, circling, or difficulty breathing.
Murine skin infection model. Six- to eight-week-old mice were subcutaneously infected with
2  106 CFU of exponential-phase cultures of S. aureus as previously described (73). Skin infection animal
work was performed according to the Guide for the Care and Use of Laboratory Animals of the National
Institutes of Health (74), the Animal Welfare Act, and U.S. Federal law. The protocol was approved by the
Animal Care and Use Committee of Rutgers New Jersey Medical School.
Construction of rexBA mutants of E. faecalis and S. gordonii. A ΔrexBA mutant was generated
in S. gordonii by in-frame allelic replacement with the erythromycin resistance determinant ermAM.
Flanking regions directly upstream and downstream of the rexBA operon were amplified by PCR from S.
gordonii DL1 genomic DNA with primer pairs Sg.rexAB.F1/Sg.rexAB.R1 and Sg.rexAB.F2/Sg.rexAB.R2
(Table 2), respectively, while the ermAM cassette was amplified from plasmid pVA838 (75) using primer pair
ermAM.SgF/ermAM.SgR (Table 2). The resulting amplimers were then joined via 20-bp overlapping regions by
stitch PCR using primers Sg.rexAB.F1/Sg.rexAB.R2 and transformed into S. gordonii. Erythromycin-resistant
transformants were confirmed by sequencing, and the strain was designated UB3018.
A rexBA mutant was generated in E. faecalis by markerless exchange using a 2-step homologous
recombination approach, as previously described (76). In brief, flanking regions directly upstream and
downstream of the rexBA operon were amplified by PCR from E. faecalis OG1X genomic DNA with primer
pairs Ef.rexAB.pheF1/Ef.rexAB.pheR1 and Ef.rexAB.pheF2/Ef.rexAB.pheR2 (Table 2), respectively, and then




StrepII rexAB SDM-F ACAATTCCAGAGAAACCACAAGGCGTGATTTGGACTGACGCGCAATGGC
StrepII rexAB SDM-R AGCGCTTTTTTCGAACTGCGGGTGGCTCCACATCTATTGCTCACCCCC
Thr rexAB SDM-F CCCGCAGTTCGAAAAAAGCGCTGGCCTGGTGCCGCGCGGCAGCGGCACAATTCCAGAGAAACCACAAGG











aUnderlined regions indicate base pair overlaps for stitch PCR, and italicized regions indicate restriction endonuclease sites for ligation into pCJK47.
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joined via 20-bp overlapping regions by stitch PCR using primer pair Ef.rexAB.pheF1/Ef.rexAB.pheR2. The
resultant amplimer was cloned into donor plasmid pCJK47 (76) via the unique restriction sites PstI and
NcoI to generate pCJK47-rexAB, propagated in E. coli EC1000, and then introduced into conjugative
donor strain E. faecalis CK111(pCF10-101) by electroporation. Plasmid pCJK47-rexAB was transferred to E.
faecalis OG1X by conjugation. Transconjugants carrying the integrated plasmid were confirmed by
colony PCR, before counterselection based on the P-pheS* marker was used to identify secondary
recombinants in which the integrated plasmid had been excised and lost, leaving the desired ΔrexBA
allele. This was confirmed by sequencing, and the strain was designated UB2948.
Construction of an S. aureus RexAB expression vector. Cloning of the rexA and rexB genes from
S. aureus was achieved by PCR from wild-type genomic JE2 DNA using the rexB-F BamHI and rexA-R SalI
primers listed in Table 2, which allowed the amplification of the rexBA operon immediately flanked by
suitable restriction endonuclease recognition sequences (BamHI and SalI). The rexA and rexB genes were
inserted into the pET28b vector (Novagen) using standard cloning techniques, and site-directed
mutagenesis (SDM) was performed to insert Strep-tag II and a thrombin site in front of the rexA gene.
This enabled RexA and RexB proteins to be detected individually via an N-terminal His6 tag for RexB (His6
from the pET28b vector) and N-terminal Strep-tag II for RexA. PCR primers for SDM are listed in Table 2.
DNA sequencing was used on the pET28b rexBA expression plasmid to confirm that the sequences of
the entire rexA and rexB genes, tags, and promoter regions were as expected.
Expression and purification of recombinant S. aureus RexAB. Cells from single colonies of E. coli
SoluBL21(DE3), freshly transformed with the pET28b rexAB expression plasmid coding for
N-terminally Strep-tag II-tagged RexA and N-terminally His6-tagged RexB, were used to inoculate a
starter culture grown overnight in LB supplemented with 50 g ml1 of kanamycin. The starter
culture was diluted to an OD600 of 0.05 into 4 liters of TB containing 50 g ml1 of kanamycin. Cells
were grown at 37°C with shaking at 180 rpm until an OD600 of 0.5 was reached, prior to induction
with 1 mM isopropyl--D-thiogalactoside (IPTG). Following induction, the temperature was reduced
to 20°C, and cultures were further incubated for 20 h. Cells were harvested by centrifugation at
10,000  g at 4°C for 30 min, and pellets were resuspended in 100 ml of a solution containing
50 mM Tris and 150 mM NaCl (pH 7.5).
For protein purification, cells were disrupted by sonication, and cell debris was cleared by centrifu-
gation at 32,000  g at 4°C for 30 min. The resulting supernatant was added to 5 ml of Chelating
Sepharose Fast Flow resin (GE Healthcare), which had been loaded with 0.1 M NiCl2 and equilibrated with
100 ml of a solution containing 50 mM Tris, 150 mM NaCl, and 20 mM imidazole (pH 7.5). The
supernatant-resin mixture was left at 4°C overnight with gentle stirring to optimize the binding of the
His-tagged protein to the nickel-charged resin. Next, the mixture was washed nine times with 40 ml of
a solution containing 50 mM Tris, 150 mM NaCl, and 20 mM imidazole (pH 7.5) and once with 20 ml of
a solution containing 50 mM Tris, 150 mM NaCl, and 70 mM imidazole (pH 7.5). His-tagged protein was
eluted with a solution containing 50 mM Tris, 150 mM NaCl, and 150 mM imidazole (pH 7.5); each 10-ml
fraction was tested with Bradford reagent (Bio-Rad) for protein content until no more protein could be
detected. Fractions containing protein were pooled, buffer exchanged, and concentrated using an
Amicon 100-kDa-cutoff concentrator (Merck Millipore); RexAB is 250 kDa. The concentrating device was
centrifuged at 2,000  g (4°C), and the protein solution was exchanged into a solution containing 50 mM
Tris and 150 mM NaCl (pH 7.5) by four serial concentration and redilution steps. The total protein
concentration was quantified using the Pierce bicinchoninic acid (BCA) protein assay kit (Thermo Fisher
Scientific) according to the manufacturer’s instructions, and the presence of intact recombinant RexAB
was confirmed via SDS-PAGE and Western blot analysis.
Nuclease and helicase activity assays. The nuclease and helicase activities of RexAB were measured
to confirm the AddAB-like activity in our recombinant RexAB protein. Staphylococcal DNA was amplified
from the JE2 whole genome by colony PCR using the primer pair Chi control F (5=-TCAGTGAATTAGAT
GATTCGC-3=) and Chi control R (5=-TTCATACGTATGAATGTTATTTGC-3=), where the amplicon lacked a Chi
site region to be used as the DNA substrate in these assays.
Reactions were set up with either nuclease assay buffer (25 mM Tris-acetate [pH 7.5], 2 mM Mg
acetate, 1 mM dithiothreitol [DTT]) or helicase assay buffer (25 mM Tris-acetate [pH 7.5], 0.25 mM Mg
acetate, 1 mM DTT), along with 5 ng l1 of DNA, 1 mM ATP or an equivalent volume of nuclease-free
water, and either 20 nM or 50 nM recombinant RexAB for the nuclease and helicase assays, respectively.
Additionally, for the helicase assay, 2 M SSB protein was added to each sample.
Samples were incubated statically at 37°C, and at 0, 5, 15, 30, 60, and 120 min, 5 l was removed and
pipetted into 20 l of STEB buffer (40% [wt/vol] sucrose, 100 mM Tris-HCl, 10 mM EDTA, 0.5 mg/ml
bromophenol blue [pH 8]) to stop the reaction. Twenty microliters of chloroform-isoamyl alcohol (24:1)
was added to each tube, vortexed for 10 s, and centrifuged for 2 min at 17,000  g to remove the protein
and any compounds used for inhibition. The aqueous (upper blue) phase was loaded onto a 1% (wt/vol)
agarose gel prepared in Tris-borate-EDTA (TBE) buffer, and electrophoresis was carried out at 85 V for 1
h. The gels were subsequently stained with SYBR Safe DNA gel stain (Invitrogen) at a 1/10,000 dilution
in TBE buffer for 2 h with rocking and visualized using a Gel Doc EZ imager (Bio-Rad). The band intensity
was quantified using ImageJ software. For nuclease activity, values were normalized to those of the
no-ATP controls at 0 h. For helicase activity, values were normalized to those of an ssDNA control that
lacked the RexAB protein, which had been heated at 95°C for 2 min to denature the dsDNA and allow
the SSB protein to bind and stabilize the two ssDNA strands.
Measurement of bacterial growth. To measure the growth of S. aureus, bacterial cultures were first
grown to stationary phase in TSB at 37°C (180 rpm) and then inoculated at a 1/50 dilution for growth
curves or a 1/10 dilution for growth inhibition assays (supplementary) into a flat-bottomed 96-well plate
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(200-l total volume) and placed into a POLARstar Omega plate reader (BMG Labtech). Bacteria were
grown for 17 h at 37°C (700 rpm), and the absorbance at 600 nm was measured every 30 min.
Hemolytic activity. The hemolytic activity of culture supernatants was determined as described
previously (77). Briefly, stationary-phase S. aureus cultures were pelleted for 5 min at 17,000  g, and
400 l of the supernatant was pipetted into microcentrifuge tubes. An equal volume of 2% defibrinated
sheep blood in PBS was added, and the mixture was incubated statically for 1 h at 37°C. Fresh TSB
containing 2% defibrinated sheep blood was used as a negative control. After incubation, the samples
were centrifuged for 5 min at 500  g, and 200 l of the supernatant was transferred into a flat-bottomed
96-well plate. The absorbance of released hemoglobin was measured at 540 nm using a POLARstar
Omega plate reader (BMG Labtech). Percent hemolysis was calculated relative to the wild-type control.
Staphyloxanthin extraction and quantification. To extract and quantify staphyloxanthin, S. aureus
stationary-phase cultures grown in TSB were harvested by centrifugation at 17,000  g for 2 min.
Staphyloxanthin was extracted by incubating the culture in methanol at 42°C for 30 min. Cells were
pelleted by centrifugation at 17,000  g for 2 min, and 100 l of the supernatant was transferred into a
flat-bottomed 96-well plate. The released staphyloxanthin was quantified by measuring the absorbance
at 462 nm using a POLARstar Omega plate reader (BMG Labtech).
Catalase activity. To determine the level of catalase activity, cultures grown overnight were washed
three times in PBS, and 107 CFU were inoculated into 1 ml of 100 M H2O2 (diluted in PBS). Samples were
incubated at 37°C, protected from light, for 15 min. Two hundred microliters of the sample was
centrifuged at 17,000  g for 3 min, and 20 l of the supernatant was added to a 96-well microtiter plate.
PBS containing no bacteria was used as a negative control.
Catalase activity was determined indirectly by measuring the concentration of H2O2 over time using
the Pierce quantitative peroxide assay kit (aqueous-compatible formulation; Thermo Fisher Scientific).
According to the manufacturer’s instructions, reagents A and B were mixed at a ratio of 1:100, and 200 l
was added to each sample in the 96-well plate. The plate was then incubated for 30 min at room
temperature, and the absorbance was measured at 595 nm using an iMark microplate reader (Bio-Rad).
The H2O2 concentration was determined using a standard curve of known concentrations (up to 1 mM).
Computational analyses. Multiple-sequence alignments were generated using Clustal Omega via
the EMBL-EBI Web server (78). Parameters were left in their default settings with the exception of
alignment “order,” which was set to consider the input order. Protein structures were predicted using the
Phyre2 protein fold recognition server (84). Phyre2 structural models were viewed and manipulated
using PyMOL molecular graphics system version 2.3 (Schrödinger).
Statistical analyses. Data are presented as the means or medians from three or more independent
experiments and were analyzed by Student’s t test (two tailed, unpaired, and assuming equal variances),
one-way analysis of variance (ANOVA), or two-way ANOVA corrected for multiple comparisons, as
described in the figure legends. For each experiment, “n” refers to the number of independent biological
replicates. CFU counts from murine experiments are presented as the values obtained from each animal,
and significance was assessed using the Mann-Whitney test. A P value of 0.05 was considered
significant between data points (GraphPad Prism 7 for Windows).
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